Replies to post #167285 on Innovation Pharmaceuticals Inc (IPIX)

[cabel]

Exactly as you said!


Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled (10 sites in US; 5 currently open to enrollment)
• 60 subjects – 30 each of drug or placebo (Water for Injection)
• “Swish and spit” brilacidin 3x/daily for 7 weeks – 16 ml oral rinse
• Interim analysis after 36 subjects (18 per treatment group) by a Data Monitoring Committee (DMC); will review safety
and efficacy results

[stevo99]

does the fact that the DMC is going to review efficacy necessarily mean they are going to publish the interim results on efficacy?

"Interim analysis after 36 subjects (18 per treatment group) by a Data Monitoring Committee (DMC); will review safety
and efficacy results"